These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27005447)

  • 1. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease.
    Vázquez-Carrera M
    Trends Endocrinol Metab; 2016 May; 27(5):319-334. PubMed ID: 27005447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance.
    Aguilar-Recarte D; Palomer X; Wahli W; Vázquez-Carrera M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
    Salvadó L; Barroso E; Gómez-Foix AM; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2014 Oct; 57(10):2126-35. PubMed ID: 25063273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.
    Salvadó L; Serrano-Marco L; Barroso E; Palomer X; Vázquez-Carrera M
    Expert Opin Ther Targets; 2012 Feb; 16(2):209-23. PubMed ID: 22280315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ.
    da Cruz BO; Cardozo LFMF; Magliano DC; Stockler-Pinto MB
    Nutr Rev; 2020 Mar; 78(3):207-214. PubMed ID: 31584650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.
    Toral M; Romero M; Pérez-Vizcaíno F; Duarte J; Jiménez R
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H189-H200. PubMed ID: 27881385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Action of Magnesium Lithospermate B against Aging and Obesity-Induced ER Stress, Insulin Resistance, and Inflammsome Formation in the Liver.
    Jeong JW; Lee B; Kim DH; Jeong HO; Moon KM; Kim MJ; Yokozawa T; Chung HY
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30134566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D; Bystrom J
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease.
    Zarei M; Aguilar-Recarte D; Palomer X; Vázquez-Carrera M
    Metabolism; 2021 Jan; 114():154342. PubMed ID: 32810487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
    Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.
    Peters JM; Foreman JE; Gonzalez FJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):619-40. PubMed ID: 22037942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
    Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
    Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
    Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.
    Coll T; Rodrïguez-Calvo R; Barroso E; Serrano L; Eyre E; Palomer X; Vázquez-Carrera M
    Curr Mol Pharmacol; 2009 Jan; 2(1):46-55. PubMed ID: 20021445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARβ/δ as a promising molecular drug target for liver diseases: A focused review.
    Meng X; Wang L; Du YC; Cheng D; Zeng T
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102343. PubMed ID: 38641250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes.
    Serrano-Marco L; Chacón MR; Maymó-Masip E; Barroso E; Salvadó L; Wabitsch M; Garrido-Sánchez L; Tinahones FJ; Palomer X; Vendrell J; Vázquez-Carrera M
    Biochim Biophys Acta; 2012 Sep; 1821(9):1177-85. PubMed ID: 22683888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression.
    Tan NS; Michalik L; Di-Poï N; Ng CY; Mermod N; Roberts AB; Desvergne B; Wahli W
    EMBO J; 2004 Oct; 23(21):4211-21. PubMed ID: 15470497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
    Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
    Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.